Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non‐alcoholic steatohepatitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|16|7|651-660

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.16, Iss.7, 2014-07, pp. : 651-660

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Failure of islet β‐cell compensation for insulin resistance causes type 2 diabetes: What causes non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis?

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 10, 2010-10 ,pp. : 1594-1597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel non‐alcoholic steatohepatitis model with histopathological and insulin‐resistant features

By  

PATHOLOGY INTERNATIONAL, Vol. 68, Iss. 1, 2018-01 ,pp. : 12-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of patients with non‐alcoholic steatohepatitis (NASH) in real life

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 52-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E42-E51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liraglutide for NASH/NAFLD

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 269-278

John Wiley & Sons Inc

Access to resources Recommend Favorite